$AIP

AIP Stock Jumps To Record High – Here’s Why This Analyst Raised Their Price Target By Nearly 120%

Arteris, Inc. (AIP) shares hit a record high after reporting Q1 revenue of $22.9M, up 39% and beating estimates. Net loss was $1.2M, better than expected. Jefferies raised its price target to $35, citing AI-driven demand. Rosenblatt also increased its target to $38, noting data center wins. AIP stock has gained 116% this year.

Original reporting
Published Aug 21, 2026, 2:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 22, 2026, 4:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AIP
Bullish
medium confidence
Mentioned
$AIP
Relevance
6/10
AlphAI data visualization · based on stocktwits.com
Decision brief

The 30-second read

$AIPBullishMed
01

Why it matters

Earnings beat and target raises could attract momentum traders, but watch operating loss guidance.

02

Market read

Micro‑cap AI‑related semiconductor IP stock showing strong earnings momentum.

03

What to watch

Potential slowdown in automotive IP revenue and reliance on a few large hyperscaler customers.

Relevance 6/10Novelty 7/10Timing: Wednesday

Background

Arteris is a semiconductor IP provider focusing on AI and data‑center markets.

Company-level read

Ticker impact

$AIPBullishMedium confidence
Context

Arteris reported Q1 revenue beat and analysts raised price targets, driving the stock to a record high.

Expected impact

Potential further rally if guidance holds, but watch for profitability concerns.

Evidence & confidence

Earnings beat is fresh news; however, small company size limits material impact.

Market effects

Highlights growing AI‑related royalty revenue in semiconductor IP space.

Limited to US micro‑cap investors.

Modest; reflects broader AI infrastructure demand.

Counterpoint

Profitability remains uncertain; higher targets may be premature.

Key entities

  • Arteris, Inc.

    Provider of semiconductor interconnect IP.

  • Jefferies

    Raised price target to $35.

  • Rosenblatt

    Raised price target to $38.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to

$IQVMedAI 8/10

IQVIA Holdings Inc (IQV) (Q3 2026) Earnings Call Highlights: Record Bookings, Raised

IQVIA Holdings Inc. reported Q3 2026 earnings with record bookings and raised guidance. Revenue was $4.428B, up 8% YoY, and adjusted EBITDA rose 8.7%. Challenges include FX headwinds and R&D backlog adjustments. Management highlighted AI adoption and strong biotech demand. Full-year 2026 guidance was increased, with revenue expected between $17.35B-$17.5B. No 2027 guidance was provided.

$AMKRMed

Amkor Technology Inc (AMKR) Q3 2026 Earnings Call Highlights: Record Computing

Amkor Technology (AMKR) reported Q3 2026 earnings, highlighting a $3B NVIDIA agreement. CEO Kevin Engel discussed expansion plans in Korea and Arizona, with Korea ramping earlier and Arizona facing higher costs. Computing grew 25%, with expectations of over 30% growth in 2026 and similar or higher in 2027. CFO Megan Faust noted Q4 gross margin improvement due to product mix, offset by FX. CapEx for 2027 is expected to exceed $2B, with potential margin impacts. Prepayments may reduce debt needs.